Literature DB >> 16164890

Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura.

Masataka Kuwana1, Yuka Okazaki, Takashi Satoh, Atsuko Asahi, Mikio Kajihara, Yasuo Ikeda.   

Abstract

PURPOSE: To identify initial laboratory findings useful for the later diagnosis of idiopathic thrombocytopenic purpura (ITP) in adult patients with thrombocytopenia. SUBJECTS AND METHODS: We studied 62 consecutive adult patients who had thrombocytopenia and whose peripheral blood film was normal except for thrombocytopenia at presentation. Each patient underwent physical examination and routine laboratory tests and was prospectively followed for 22.5 +/- 9.8 months (range, 8 to 41 months). The frequency of antiglycoprotein (GP) IIb/IIIa antibody-producing B cells, the presence of platelet-associated and plasma anti-GPIIb/IIIa antibodies, the percentage of reticulated platelets, and the plasma thrombopoietin level were examined at the first visit. The final diagnosis was based on the clinical history, physical examination, complete blood test, bone marrow findings, and the clinical course at last observation.
RESULTS: Forty-six patients were diagnosed as having ITP and 16 as having another disorder, including myelodysplastic syndrome, aplastic anemia, amegakaryocytic thrombocytopenia, and reduced platelet production, with or without other cytopenias, and without dysplasia or evidence for destruction. Six initial laboratory findings discriminated ITP from other diagnoses: the absence of anemia, absence of leukocytopenia, increased frequency of anti-GPIIb/IIIa antibody-producing B cells, increased platelet-associated anti-GPIIb/IIIa antibodies, elevated percentage of reticulated platelets, and a normal or slightly increased plasma thrombopoietin level. Three or more of these ITP-associated findings were found at presentation in 44 patients (96%) with thrombocytopenia later diagnosed as ITP, compared with only 1 patient (6%) whose disorder was non-ITP.
CONCLUSION: Initial laboratory findings can well predict future diagnosis of ITP. Further studies prospectively evaluating these same diagnostic criteria on another, independent set of patients are necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164890     DOI: 10.1016/j.amjmed.2004.12.027

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Primary autoimmune myelofibrosis with severe thrombocytopenia mimicking immune thrombocytopenia: A case report.

Authors:  Jian Hua; Shu Matayoshi; Tomoyuki Uchida; Morihiro Inoue; Masao Hagihara
Journal:  Mol Clin Oncol       Date:  2016-10-26

2.  B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis.

Authors:  Takashi Satoh; Hayato Takiguchi; Haruki Uojima; Makoto Kubo; Chisato Tanaka; Fumiko Yokoyama; Naohisa Wada; Koji Miyazaki; Hisashi Hidaka; Chika Kusano; Masataka Kuwana; Ryouichi Horie
Journal:  Ann Hematol       Date:  2022-09-13       Impact factor: 4.030

3.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.

Authors:  Naohisa Wada; Haruki Uojima; Takashi Satoh; Sosei Okina; Shuichiro Iwasaki; Xue Shao; Hayato Takiguchi; Yoshitaka Arase; Norio Itokawa; Masanori Atsukawa; Koji Miyazaki; Hisashi Hidaka; Makoto Kako; Tatehiro Kagawa; Katsuhiko Iwakiri; Ryouichi Horie; Takahiro Suzuki; Wasaburo Koizumi
Journal:  Dig Dis       Date:  2020-08-06       Impact factor: 2.404

Review 5.  The thrombocytopenia of WAS: a familial form of ITP?

Authors:  Ted S Strom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia.

Authors:  Satoshi Horino; Takeshi Rikiishi; Hidetaka Niizuma; Hiroshi Abe; Yuko Watanabe; Masaei Onuma; Yoshiyuki Hoshi; Yoji Sasahara; Miyako Yoshinari; Takuro Kazama; Yutaka Hayashi; Satoru Kumaki; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2009-10-10       Impact factor: 2.490

7.  Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.

Authors:  Atsuko Asahi; Tetsuya Nishimoto; Yuka Okazaki; Hidekazu Suzuki; Tatsuhiro Masaoka; Yutaka Kawakami; Yasuo Ikeda; Masataka Kuwana
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 8.  The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Authors:  Rita Consolini; Annalisa Legitimo; Maria Costanza Caparello
Journal:  Front Pediatr       Date:  2016-10-19       Impact factor: 3.418

9.  Idiopathic thrombocytopenic purpura.

Authors:  L Kayal; S Jayachandran; Khushboo Singh
Journal:  Contemp Clin Dent       Date:  2014-07

10.  Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia.

Authors:  Asmaa M Zahran; Sanaa Shaker Aly; Ahmed Elabd; Ismail Lotfy Mohamad; Khalid I Elsayh
Journal:  J Hematol       Date:  2017-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.